Andersen Cascade Impactor

Andersen Cascade Impactor Market Outlook

The global Andersen Cascade Impactor market is projected to reach approximately USD 250 million by 2035, growing at a robust compound annual growth rate (CAGR) of around 8.5% during the forecast period from 2025 to 2035. This growth is primarily driven by the rising prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), which necessitate effective inhalation device testing and particulate sampling solutions. Additionally, the increasing demand for advanced drug delivery systems in the pharmaceutical sector is pushing the market towards innovation and product development. Furthermore, the growing investment in research and development activities by pharmaceutical companies and research institutions is expected to significantly contribute to market expansion. As regulatory frameworks become more stringent concerning aerosol delivery systems, the adoption of Andersen Cascade Impactors is anticipated to rise, reflecting the importance of precision in pharmaceutical testing.

Growth Factor of the Market

One of the primary growth factors for the Andersen Cascade Impactor market is the increasing incidence of respiratory disorders, which has heightened the focus on effective inhalation therapies. The World Health Organization (WHO) estimates that around 300 million individuals suffer from asthma, and over 250 million have COPD globally, further emphasizing the need for reliable testing platforms. Moreover, as drug formulations evolve, the demand for precise characterization of aerosolized particles becomes critical, leading to the adoption of cascade impactors in various research settings. Furthermore, advancements in technology, including the development of next-generation impactors, have improved the efficiency and accuracy of particle size distribution measurements. The expanding pharmaceutical industry, driven by increased drug development activities, is also a significant factor contributing to market growth. Additionally, the rising awareness of the importance of quality control in drug manufacturing processes has propelled the demand for reliable testing devices like the Andersen Cascade Impactor.

Key Highlights of the Market

• Projected market value of USD 250 million by 2035.
• CAGR of 8.5% during the forecast period from 2025 to 2035.
• Increasing prevalence of respiratory diseases driving demand for inhalation devices.
• Advancements in technology leading to innovative product development.
• Growing emphasis on regulatory compliance and quality control in pharmaceutical testing.

By Product Type

Micro Orifice Cascade Impactor:

The Micro Orifice Cascade Impactor (MOCI) segment is gaining traction due to its ability to accurately measure the aerodynamic particle size distribution of aerosolized drugs. Its design allows for the separation of particles based on their size, making it an essential tool for testing inhalation devices. As the demand for precise particle size characterization grows, the MOCI's advanced features are becoming increasingly relevant. Many pharmaceutical companies prefer the MOCI for Formulation Development, ensuring optimal delivery of medication to patients. The growing focus on personalized medicine and targeted therapies is also expected to bolster the MOCI segment further, as it provides critical insights needed to optimize drug formulations. Thus, the MOCI plays a pivotal role in the development of new inhalation therapies, driving its market share within the Andersen Cascade Impactor segment.

Multi-Stage Cascade Impactor:

The Multi-Stage Cascade Impactor (MSCI) represents a significant segment within the Andersen Cascade Impactor market by providing a comprehensive solution for particle size analysis. Its multi-stage design allows for the separation of particles into multiple size fractions, enabling detailed analysis of aerosolized pharmaceuticals. This capability is crucial for inhaler testing, as it helps ensure that the correct dosage reaches the lower respiratory tract. The MSCI is widely used in both research and quality control settings, driven by its versatility and efficiency in particle characterization. Furthermore, with increasing regulatory scrutiny on aerosol delivery systems, the demand for MSCIs is projected to rise. The growing trend towards developing combination therapies and complex formulations will also drive the need for advanced testing systems like the MSCI, as pharmaceutical companies seek to enhance product performance and patient outcomes.

Next Generation Impactor:

Next Generation Impactors (NGIs) are at the forefront of technological advancements in aerosol science, making them a crucial segment in the Andersen Cascade Impactor market. These devices offer superior performance, including improved accuracy and versatility in testing various inhalation products. The NGIs are particularly favored for their ability to simulate human lung conditions closely, providing relevant data for inhalation therapies. This capability is essential for addressing the growing demand for precision medicine tailored to individual patient needs. With an emphasis on developing new inhalation therapies and an increased focus on patient-centric approaches, the NGI segment is poised for significant growth. Additionally, ongoing research and innovation in inhalation device technology will further solidify the position of NGIs in the market, appealing to pharmaceutical companies and regulatory agencies alike.

By Application

Inhaler Testing:

The inhaler testing segment holds a significant share of the Andersen Cascade Impactor market, driven by the increasing use of inhalation therapies for respiratory conditions. Accurate inhaler testing is vital for ensuring that patients receive the intended dosage of medication effectively. The need for reliable testing methodologies is emphasized by stringent regulatory requirements, prompting pharmaceutical companies to invest in advanced testing solutions. Andersen Cascade Impactors are widely adopted for their ability to provide detailed information on aerosol performance, including particle size distribution and deposition patterns. As more inhalation devices are developed and introduced to the market, the demand for effective inhaler testing solutions is expected to grow, solidifying the importance of impedance technologies in the healthcare landscape.

Particulate Sampling:

Particulate sampling is another crucial application for Andersen Cascade Impactors, utilized across various industries, including environmental monitoring and pharmaceutical testing. The capability of cascade impactors to collect and analyze airborne particulates makes them essential tools for understanding air quality and aerosol behavior. Increased awareness of environmental health issues has driven demand for effective particulate sampling solutions. Furthermore, regulatory bodies are enforcing stricter guidelines for air quality standards, leading organizations to adopt advanced sampling techniques. This growing emphasis on particulate monitoring, coupled with technological advancements in cascade impactor design, is expected to propel the particulate sampling application segment within the Andersen Cascade Impactor market.

Spray Characterization:

Spray characterization is an essential application of Andersen Cascade Impactors, particularly in the development of aerosol-based products. The ability to analyze spray patterns, droplet sizes, and distribution profiles is critical for optimizing formulations used in various industries, including pharmaceuticals and personal care. With the increasing demand for aerosol products, the need for precise spray characterization is more prominent than ever. Andersen Cascade Impactors provide reliable data that help manufacturers refine their formulations, ensuring effective delivery and performance. As the aerosol market continues to expand, the significance of spray characterization applications in the Andersen Cascade Impactor market is anticipated to grow, driven by innovation in product development.

Dry Powder Inhaler Testing:

Dry powder inhaler (DPI) testing is a rapidly growing application segment within the Andersen Cascade Impactor market, attributed to the rising popularity of DPI devices for delivering medication to patients with respiratory diseases. The ability of Andersen Cascade Impactors to assess the aerodynamic properties of dry powders is essential for evaluating their effectiveness. Accurate DPI testing ensures that patients receive the appropriate dosage and optimal therapeutic effect. As the prevalence of respiratory ailments continues to rise, the development and testing of DPIs are becoming increasingly critical. Consequently, the Andersen Cascade Impactor's role in DPI testing is expected to expand, providing vital data to support the advancement of dry powder formulations in the pharmaceutical industry.

By User

Pharmaceutical Companies:

Pharmaceutical companies represent a significant user segment of the Andersen Cascade Impactor market, given their reliance on accurate testing methodologies for inhalation products. The rigorous testing and development processes for new drugs necessitate the use of advanced technologies, such as cascade impactors, to evaluate aerosol performance. These companies are increasingly investing in Andersen Cascade Impactors to ensure compliance with regulatory standards and to enhance the quality of their formulations. As the demand for inhalation therapies continues to rise, pharmaceutical companies will increasingly turn to Andersen Cascade Impactors for their testing needs, thereby driving the growth of this segment within the market. Moreover, the competition among pharmaceutical firms to develop effective and safe inhalation therapies further propels the demand for precise testing solutions.

Research Institutes:

Research institutes are essential users of Andersen Cascade Impactors, as they play a crucial role in advancing aerosol science and inhalation therapy technologies. These institutions utilize cascade impactors for various research purposes, including drug formulation studies, aerosol characterization, and environmental monitoring. The need for accurate and reliable data drives research institutes to adopt advanced testing methodologies, ensuring their findings contribute to the broader scientific community. As research into aerosols continues to expand, particularly concerning respiratory diseases, the role of Andersen Cascade Impactors in these initiatives will become increasingly significant. The collaboration between research institutes and pharmaceutical companies to enhance drug delivery systems will further reinforce the demand for cascade impactors in this user segment.

CROs:

Contract Research Organizations (CROs) comprise a growing user segment within the Andersen Cascade Impactor market, as they provide essential testing and research services to pharmaceutical and biotechnology companies. CROs are increasingly relied upon to conduct comprehensive inhaler testing and aerosol characterization studies, leveraging advanced technologies such as Andersen Cascade Impactors. The outsourcing of research and testing activities to CROs is driven by the need for expertise and capacity, allowing pharmaceutical companies to focus on core activities. As the demand for inhalation therapies continues to rise, CROs will play an increasingly vital role in providing the necessary testing services, thus driving the growth of the Andersen Cascade Impactor market within this segment. The collaboration between CROs and pharmaceutical companies is expected to foster innovation and expedite the development of new inhalation products.

By Indication

Asthma:

The asthma indication segment represents a significant portion of the Andersen Cascade Impactor market, driven by the increasing prevalence of this respiratory condition globally. Asthma affects millions of individuals, necessitating effective inhalation therapies for management. The use of Andersen Cascade Impactors in the development and testing of asthma medications is crucial, as precise aerosol delivery is essential for therapeutic success. Pharmaceutical companies and research institutions utilize cascade impactors to ensure that inhaled medications effectively reach the lungs. The growing awareness of asthma management and treatment is anticipated to propel the demand for inhalation products, subsequently driving the market for Andersen Cascade Impactors in this indication segment. As a result, the collaboration between healthcare providers, pharmaceutical companies, and research institutes will further enhance the development of effective inhalation therapies for asthma patients.

COPD:

The Chronic Obstructive Pulmonary Disease (COPD) indication segment is experiencing substantial growth within the Andersen Cascade Impactor market, attributed to the rising incidence of this debilitating condition. COPD requires long-term management through inhalation therapies, necessitating accurate testing and formulation development. Andersen Cascade Impactors play a vital role in ensuring that aerosolized medications effectively target the lungs, providing optimal therapeutic outcomes. The focus on improving the quality of life for COPD patients has driven pharmaceutical companies to invest in innovative testing solutions, including cascade impactors. As the prevalence of COPD continues to increase, the demand for targeted inhalation therapies will drive the growth of Andersen Cascade Impactors, solidifying their importance in this indication segment.

Cystic Fibrosis:

The cystic fibrosis indication segment is emerging as a vital area within the Andersen Cascade Impactor market, driven by the need for effective inhalation therapies for this genetic disorder. Patients with cystic fibrosis often require specialized medications delivered through aerosolized means, highlighting the importance of precise aerosol characterization. Andersen Cascade Impactors are utilized to ensure that formulations are optimized for effective delivery to the lungs. As advances in treatment options for cystic fibrosis continue to evolve, the demand for reliable testing methodologies will escalate. The collaboration among pharmaceutical companies, researchers, and healthcare professionals will further enhance the development of inhalation therapies tailored to individuals with cystic fibrosis, propelling the growth of the Andersen Cascade Impactor market in this indication segment.

By Region

North America holds a significant market share of the Andersen Cascade Impactor market, driven by the presence of major pharmaceutical companies and advanced healthcare infrastructure. The region is characterized by high investments in research and development activities, particularly in the field of inhalation therapies and aerosol science. The increasing prevalence of respiratory diseases, such as asthma and COPD, has led to a growing demand for effective inhalation devices, which, in turn, drives the need for reliable testing methodologies. According to industry analysis, the North American market is expected to grow at a CAGR of 9% from 2025 to 2035. Additionally, stringent regulatory standards governing the pharmaceutical industry in this region necessitate the use of advanced testing technologies, further propelling the demand for Andersen Cascade Impactors.

Europe follows closely, accounting for a substantial share of the Andersen Cascade Impactor market, fueled by a robust pharmaceutical industry and increasing focus on aerosol therapy. The region's aging population and rising incidence of respiratory disorders are significant factors driving market growth. European countries are investing in advanced aerosol delivery systems, leading to a heightened demand for effective testing and characterization solutions. The ongoing advancements in drug formulation and delivery technologies are also contributing to market expansion in this region. As the European Union continues to enforce stringent regulations on inhalation devices, the need for precise testing methodologies, such as Andersen Cascade Impactors, is expected to grow, ensuring the delivery of safe and effective therapies to patients.

Opportunities

There are numerous opportunities within the Andersen Cascade Impactor market, particularly as the healthcare industry continues to evolve in response to the increasing prevalence of respiratory diseases. The growing emphasis on precision medicine and personalized healthcare presents a unique opportunity for Andersen Cascade Impactors. As pharmaceutical companies focus on developing targeted inhalation therapies, the demand for advanced testing methodologies that provide accurate data on aerosol performance will rise. Innovations in cascade impactor technology, such as the integration of real-time monitoring systems and enhanced data analytics capabilities, could further elevate the product offerings. By investing in research and development, manufacturers can create next-generation Andersen Cascade Impactors that meet the changing needs of the pharmaceutical industry, positioning themselves favorably in an increasingly competitive landscape.

Additionally, the ongoing globalization of the pharmaceutical market presents opportunities for organizations to expand their reach. Emerging markets in Asia Pacific and Latin America are witnessing rapid growth in the healthcare sector, driven by rising disposable incomes and increased access to healthcare services. This expansion creates potential demand for Andersen Cascade Impactors as pharmaceutical and research companies in these regions seek reliable testing solutions. Furthermore, collaborations and partnerships between companies and research institutions can accelerate innovation and development in aerosol science, creating a synergistic approach to addressing the challenges in inhalation therapy testing. By capitalizing on these opportunities, players in the Andersen Cascade Impactor market can drive growth and enhance their market presence over the coming years.

Threats

Despite the promising growth of the Andersen Cascade Impactor market, several threats could impede its progress. One of the significant challenges is the rapid pace of technological advancements in the field of aerosol science, which may lead to the emergence of alternative testing methodologies. Newer technologies may provide comparable or superior capabilities, potentially displacing traditional cascade impactors. This threat is compounded by the increasing competition among manufacturers, leading to price pressures that could impact profitability. Moreover, the evolving regulatory landscape poses challenges for product compliance, as companies must continually adapt to meet new standards and requirements. Failing to comply with regulatory guidelines may result in product recalls or sanctions, further threatening market stability. Therefore, companies need to focus on innovation, quality assurance, and regulatory compliance to mitigate these threats effectively.

Another critical challenge for the Andersen Cascade Impactor market is the potential for supply chain disruptions. The global pandemic and geopolitical tensions have demonstrated the vulnerabilities within supply chains, affecting the availability of raw materials and components necessary for manufacturing cascade impactors. Such disruptions could lead to production delays and increased operational costs, ultimately affecting the market's growth trajectory. Additionally, fluctuations in demand for inhalation therapies due to changing healthcare priorities and economic challenges can impact the overall market. Organizations must develop robust risk management strategies to navigate these uncertainties and ensure business continuity in the face of potential supply chain disruptions. By proactively addressing these threats, companies can maintain their competitive edge and sustain growth in an evolving market landscape.

Competitor Outlook

• Thermo Fisher Scientific
• MSP Corporation
• Palas GmbH
• Hauke GmbH
• Hovione
• QSI Environmental
• Emerson
• Ennovent
• Cambridge Isotope Laboratories
• Teledyne Technologies
• Malvern Panalytical
• Aerogen
• Met One Instruments
• Siemens
• Metrohm

The competitive landscape of the Andersen Cascade Impactor market is characterized by a mix of established players and emerging companies. Major companies are focusing on innovation and technological advancements to enhance their product offerings, ensuring that their cascade impactors meet the evolving demands of the pharmaceutical and research industries. Many of these companies are investing in research and development to create next-generation impactors that provide superior accuracy and efficiency in aerosol performance testing. Additionally, strategic partnerships and collaborations between manufacturers and research institutions have become common, enabling knowledge sharing and accelerating product development. These alliances are critical in addressing the challenges faced by the industry and fostering innovation in aerosol science.

Key players in the Andersen Cascade Impactor market, such as Thermo Fisher Scientific and MSP Corporation, have established a strong foothold through a diverse portfolio of products and services. Thermo Fisher Scientific, a leading provider of scientific instruments, offers a range of cascade impactors suitable for various applications, including inhaler testing and particulate sampling. The company has consistently invested in research and development to enhance the performance of its products. Similarly, MSP Corporation is known for its cutting-edge technologies in aerosol characterization, offering robust cascade impactor solutions tailored to the pharmaceutical industry’s needs. Additionally, Hauke GmbH and Hovione are also significant players in the market, leveraging their expertise and innovation to deliver high-quality cascade impactors that address customer demands.

Emerging companies in the Andersen Cascade Impactor market are also making their mark by focusing on niche applications and specialized solutions. For instance, QSI Environmental and Malvern Panalytical are developing advanced technologies that integrate data analytics and real-time monitoring capabilities into their cascade impactors. These innovations are designed to enhance the user experience and provide actionable insights to customers, further driving demand for their products. As the market continues to grow, it will be essential for both established and emerging companies to adapt to changing market dynamics, invest in product development, and forge strategic partnerships to maintain competitiveness and achieve sustainable growth.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Aerogen
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Emerson
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hovione
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Metrohm
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Siemens
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Ennovent
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Hauke GmbH
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Palas GmbH
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 MSP Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 QSI Environmental
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Malvern Panalytical
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Met One Instruments
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Teledyne Technologies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Cambridge Isotope Laboratories
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Andersen Cascade Impactor Market, By User
    • 6.1.1 Pharmaceutical Companies
    • 6.1.2 Research Institutes
    • 6.1.3 CROs
    • 6.1.4 Others
  • 6.2 Andersen Cascade Impactor Market, By Indication
    • 6.2.1 Asthma
    • 6.2.2 COPD
    • 6.2.3 Cystic Fibrosis
    • 6.2.4 Others
  • 6.3 Andersen Cascade Impactor Market, By Application
    • 6.3.1 Inhaler Testing
    • 6.3.2 Particulate Sampling
    • 6.3.3 Spray Characterization
    • 6.3.4 Dry Powder Inhaler Testing
    • 6.3.5 Others
  • 6.4 Andersen Cascade Impactor Market, By Product Type
    • 6.4.1 Micro Orifice Cascade Impactor
    • 6.4.2 Multi-Stage Cascade Impactor
    • 6.4.3 Next Generation Impactor

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Andersen Cascade Impactor Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Andersen Cascade Impactor market is categorized based on

By Product Type

• Micro Orifice Cascade Impactor
• Multi-Stage Cascade Impactor
• Next Generation Impactor

By Application

• Inhaler Testing
• Particulate Sampling
• Spray Characterization
• Dry Powder Inhaler Testing
• Others

By User

• Pharmaceutical Companies
• Research Institutes
• CROs
• Others

By Indication

• Asthma
• COPD
• Cystic Fibrosis
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• MSP Corporation
• Palas GmbH
• Hauke GmbH
• Hovione
• QSI Environmental
• Emerson
• Ennovent
• Cambridge Isotope Laboratories
• Teledyne Technologies
• Malvern Panalytical
• Aerogen
• Met One Instruments
• Siemens
• Metrohm